Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,991 | 247 | 86.1% |
| Honoraria | $500.00 | 1 | 7.2% |
| Education | $331.18 | 6 | 4.8% |
| Consulting Fee | $100.00 | 1 | 1.4% |
| Entertainment | $38.84 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $918.25 | 38 | $0 (2023) |
| Janssen Biotech, Inc. | $681.33 | 36 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $644.62 | 29 | $0 (2022) |
| Verity Pharmaceuticals Inc. | $608.23 | 6 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $600.31 | 16 | $0 (2024) |
| Amniox Medical, Inc. | $374.05 | 5 | $0 (2020) |
| Axonics, Inc. | $285.31 | 9 | $0 (2024) |
| PFIZER INC. | $234.15 | 11 | $0 (2022) |
| Antares Pharma, Inc. | $224.74 | 8 | $0 (2024) |
| ABBVIE INC. | $205.56 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 29 | Verity Pharmaceuticals Inc. ($554.66) |
| 2023 | $1,324 | 44 | Myriad Genetic Laboratories, Inc. ($435.48) |
| 2022 | $1,136 | 55 | Astellas Pharma US Inc ($238.64) |
| 2021 | $720.21 | 35 | Endo Pharmaceuticals Inc. ($149.82) |
| 2020 | $586.72 | 19 | Amniox Medical, Inc. ($239.61) |
| 2019 | $854.90 | 28 | Astellas Pharma US Inc ($156.31) |
| 2018 | $539.86 | 21 | Augmenix, Inc. ($190.07) |
| 2017 | $634.20 | 25 | Endo Pharmaceuticals Inc. ($272.94) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Prostate cancer | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Oncology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: rezum_URO | ||||||
| 10/17/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/10/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diagnostic Imaging | ||||||
| 08/13/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $27.85 | General |
| Category: Prostate cancer | ||||||
| 08/06/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Urology | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/04/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Urology Gynecology | ||||||
| 06/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/03/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Urology | ||||||
| 05/08/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: UROLOGY | ||||||
| 04/18/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 03/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 913 | 1,394 | $363,989 | $85,024 |
| 2022 | 8 | 845 | 1,210 | $340,080 | $78,063 |
| 2021 | 10 | 835 | 1,185 | $307,192 | $84,722 |
| 2020 | 9 | 656 | 903 | $224,372 | $52,320 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 371 | $152,893 | $36,693 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 222 | $64,829 | $14,466 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 106 | 106 | $57,700 | $12,299 | 21.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 33 | 42 | $32,831 | $8,397 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 48 | $20,742 | $5,218 | 25.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 51 | 52 | $18,137 | $4,743 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 300 | 539 | $11,460 | $1,824 | 15.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $5,398 | $1,384 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 337 | $139,353 | $32,161 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 223 | $66,024 | $14,212 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $54,021 | $12,354 | 22.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 28 | 36 | $28,958 | $7,408 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 48 | 49 | $22,243 | $5,574 | 25.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 46 | 49 | $17,881 | $4,078 | 22.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 257 | 400 | $8,000 | $1,363 | 17.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 11 | 17 | $3,600 | $912.99 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 210 | 372 | $130,103 | $37,389 | 28.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 134 | 183 | $43,272 | $12,775 | 29.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $47,473 | $11,280 | 23.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 70 | 76 | $34,499 | $8,841 | 25.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 25 | 34 | $18,669 | $6,725 | 36.0% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 42 | 45 | $16,421 | $4,169 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 14 | $4,797 | $1,230 | 25.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 231 | 347 | $6,940 | $1,197 | 17.2% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 12 | 14 | $2,965 | $713.14 | 24.1% |
About Dr. Jay Kim, MD
Dr. Jay Kim, MD is a Urology healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922000447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Kim, MD has received a total of $6,961 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 256 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($5,991).
As a Medicare-enrolled provider, Kim has provided services to 3,249 Medicare beneficiaries, totaling 4,692 services with total Medicare billing of $300,129. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Aventura, FL
- Active Since 08/15/2005
- Last Updated 02/10/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1922000447
Products in Payments
- ERLEADA (Drug) $604.71
- Trelstar (Drug) $581.42
- XIAFLEX (Biological) $578.55
- NEOX (Biological) $374.05
- XTANDI (Drug) $353.56
- Axonics (Device) $285.31
- MYRBETRIQ (Drug) $269.02
- Myrbetriq (Drug) $239.64
- SpaceOAR (Device) $190.07
- NOCDURNA (Drug) $186.56
- PROLARIS (Device) $154.29
- Prolaris (Device) $146.49
- ORGOVYX (Drug) $127.64
- ELIGARD (Drug) $122.02
- KEYTRUDA (Biological) $119.67
- ILLUCCIX (Drug) $113.14
- GrafixPL (Biological) $110.98
- XYOSTED (Drug) $102.16
- LYNPARZA (Drug) $102.01
- BOTOX (Biological) $92.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Aventura
Jonathan Silberstein, M.d, M.D
Urology — Payments: $545,773
Boris Klopukh, Md, MD
Urology — Payments: $7,464
Floyd Seskin, Md, MD
Urology — Payments: $7,077
Giridhar Talluri, Md, MD
Urology — Payments: $4,850
Mark Weitzenfeld, Md, MD
Urology — Payments: $4,250
Dr. Richard Levin, Md, MD
Urology — Payments: $3,092